Showing results (521-530 of 638) with videos related to
Sort By:
Pageof 64
Ophthalmology|April 9, 2013
Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoidsGareth J McKay, Edward Loane, John M Nolan, et al.JAMA|January 9, 2024
Social Risk and Dialysis Facility Performance in the First Year of the ESRD Treatment Choices ModelKalli G Koukounas, Rebecca Thorsness, Rachel E Patzer, et al.Chemistryselect|July 8, 2026
Synthesis of β-fluoropyrrolidines designed to reduce hERG affinity in a class of antiparasitic compoundsTanner J Schubert, Guadalupe Calixto, Katelyn B Richter, et al.Cancer|February 11, 2004
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139Mark M Zalupski, Cathryn Rankin, James R Ryan, et al.Cancer|August 14, 2002
HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening TrialPrimo N Lara, Frederick J Meyers, Carl R Gray, et al.Molecular Ecology|May 14, 2017
A test of genomic modularity among life-history adaptations promoting speciation with gene flowGregory J Ragland, Meredith M Doellman, Peter J Meyers, et al.Nature|October 14, 2008
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchangeYi Liu, Renaud Dentin, Danica Chen, et al.Shock (Augusta, Ga.)|September 4, 2020
High Versus Low Volume Fluid Resuscitation Strategies in a Porcine Model (Sus scrofa) of Combined Thermal and Traumatic Brain InjuryTimothy M Guenther, Marguerite W Spruce, Lindsey M Bach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.International Journal of Molecular Sciences|December 11, 2022
Microglia-Derived Olfactomedin-like 3 Is a Potent Angiogenic Factor in Primary Mouse Brain Endothelial Cells: A Novel Target for GlioblastomaLaila M Joseph, Ryan G Toedebusch, Eshetu Debebe, et al.Pageof 64